|
|
|
|
|
|
|
Infectious diseases are an increasingly formidable public health problem throughout the world.
Developed nations face the rapid emergence of resistant pathogens. Innovative therapies, while highly
valuable, are often reserved for the last line of defense. Other regions may lack the funds or infrastructure
to provide reliable access to life-saving diagnostics and treatments. Health Advances is sensitive to balancing
the requirements of different markets with the challenges of developing new products. As an example, we are
currently supporting a client's rollout of a new HIV diagnostic in over 35 countries.
- Hepatitis B
- Hepatitis C
- HIV
- Malaria
- Nosocomial Infections
- Otitis Media
- Post-Surgical Infections
- Sepsis
- Sexually Transmitted Diseases (STDs)
- Sinusitis
- Tuberculosis
- Urinary Tract Infections
- Ventilator Acquired Pneumonia (VAP)
- Wound Infections
|
|
 |
|
|
|
|
|
|
